Anal Adenocarcinoma — Trials

Anal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02407561	Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays	terminated	—	3	Castle Biosciences IncorporatedINDUSTRY	1	Jan 25, 2018	clinicaltrials

Data updated 22 days agoSource updated Jan 25, 2018source: clinicaltrials